Lv0
0 积分 2023-08-30 加入
Interferons: Invited guests at the brain’s gala banquet
7个月前
已完结
Two inhibitory neuronal classes govern acquisition and recall of spinal sensorimotor adaptation
7个月前
已完结
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF
7个月前
已完结
Cell-type-resolved mosaicism reveals clonal dynamics of the human forebrain
7个月前
已完结
Control of adaptive immunity by pattern recognition receptors
7个月前
已完结
Innate immune activation in neurodegenerative diseases
7个月前
已完结
HDAC3 stokes microglia in stroke
7个月前
已完结
Adis Insight Drug Profile MGC 028 ！
7个月前
已关闭
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
7个月前
已完结
Synaptic Integration at Neuron-OPC Synapses
7个月前
已完结
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
9个月前
已采纳
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
9个月前
已采纳
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
9个月前
已采纳
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
9个月前
已采纳
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
9个月前
已采纳
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
9个月前
已采纳
The paradoxical role of zinc on microglia
9个月前
已采纳
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology
9个月前
已采纳
Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2
9个月前
已采纳
Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2
9个月前
已采纳
皖公网安备34019202002308
